Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.
Publication Title
European urology
Document Type
Article
Publication Date
5-21-2024
Keywords
oregon; chiles
Clinical Institute
Cancer
Specialty/Research Institute
Oncology
DOI
10.1016/j.eururo.2024.05.003
COinS